The incretin pathway as a new therapeutic target for obesity

Maturitas
Thomas M BarberJonathan Levy

Abstract

The global obesity epidemic fuelled by our obesogenic environment, and the prevention and treatment of obesity are some of the most important health-care challenges of our time. Although influenced largely by genetic factors, body mass index (BMI) is also heavily dependent upon environmental (principally dietary) factors. Whilst bariatric surgery often results in weight loss, its associated cost is prohibitive for widespread application. Current options for medical treatment of obesity are limited by recent withdrawals of Rimonabant and Sibutramine, enhancing the need for further development of novel weight-loss drugs. The incretin effect results from release of the incretin hormones Glucagon like peptide-1 (GLP-1) and Glucose-dependent insulinotropic polypeptide (GIP) from intestinal cells in response to glucose ingestion. This in turn has direct effects on the endocrine pancreas to enhance insulin release in a glucose-dependent manner and suppress glucagon release, the net effects of which are to reduce post-prandial excursions of plasma glucose. Administration of novel GLP-1-mimetic therapies to patients with type 2 diabetes mellitus (T2D) has been shown to improve and stabilise glycaemic control. In addition, such treatment...Continue Reading

References

Jan 1, 1986·Diabetologia·M NauckW Creutzfeldt
Jan 26, 1999·JAMA : the Journal of the American Medical Association·M H DavidsonS B Heymsfield
Jul 31, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·C VerdichA Astrup
Apr 4, 2003·Diabetes/metabolism Research and Reviews·Josephine M EganRiccardo Perfetti
Mar 10, 2004·The British Journal of Nutrition·Erik NäslundP M Hellström
May 18, 2005·Obesity Research·Tanja C M AdamMargriet S Westerterp-Plantenga
Aug 5, 2006·Clinical Endocrinology·T M BarberS Franks
Sep 22, 2006·Human Molecular Genetics·Andrew J WalleyPhilippe Froguel
Jan 19, 2007·The New England Journal of Medicine·Parvez HossainMeguid El Nahas
Apr 27, 2007·Journal of Pediatric Gastroenterology and Nutrition·Thomas ReinehrChristian L Roth
May 15, 2007·Nature Genetics·Christian DinaPhilippe Froguel
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Nov 8, 2007·JAMA : the Journal of the American Medical Association·Dawn E Alley, Virginia W Chang
Nov 17, 2007·BMJ : British Medical Journal·Diana RuckerDavid C W Lau
May 8, 2008·The Annals of Pharmacotherapy·Christine Kircher, Katherine P Smith
Sep 13, 2008·Molecular and Cellular Endocrinology·Jens Juul HolstCarolyn F Deacon
Jun 2, 2009·The American Journal of Medicine·David M KendallRichard M Bergenstal
Jun 30, 2009·Pharmacology & Therapeutics·Marianne T Neary, Rachel L Batterham
Aug 8, 2009·Diabetes/metabolism Research and Reviews·Michelle C Venables, Asker E Jeukendrup
Aug 19, 2009·Diabetologia·D Russell-JonesUNKNOWN Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group
Jan 12, 2010·Annual Review of Medicine·Francesco RubinoDavid E Cummings
Feb 16, 2010·Diabetes & Metabolism·G Mingrone, L Castagneto-Gissey
Apr 8, 2010·The Annals of Pharmacotherapy·Sarah L Anderson, Jennifer M Trujillo

❮ Previous
Next ❯

Citations

Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Rupa Ahluwalia, Jiten Vora
Jun 4, 2013·Lipids in Health and Disease·Elisa WaldmannKlaus G Parhofer
Nov 8, 2011·The Surgical Clinics of North America·Chan W Park, Alfonso Torquati
Apr 9, 2011·New Biotechnology·Bianca Ahrens
Apr 12, 2016·Drug Discoveries & Therapeutics·Yue Chen
Sep 25, 2012·Journal of Veterinary Science·Hsien Yueh LiuCicero Lee-Tian Chang
Apr 23, 2016·Annals of the American Thoracic Society·Takeshi MatsumotoKazuo Chin
Jun 23, 2012·Digestive Diseases·Maja Baretić
Jan 24, 2019·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Maryam RameshradHossein Hosseinzadeh
Apr 24, 2020·Bioorganic Chemistry·Xinxian DengFaqin Jiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Related Papers

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Owais ChaudhriSteve Bloom
Trends in Cardiovascular Medicine
Marek TreimanJan Skov Jensen
© 2021 Meta ULC. All rights reserved